FLXN
Horizon Flexible Income ETF
stockBATS
At CloseOct 21, 2026 3:03:29 PM EDT
24.06USD0.000%(+24.06)5,228
Loading…
Loading…
Sector
Healthcare
Industry
Drug Manufacturers
CEO
Michael Clayman
HQ
Burlington, Massachusetts, USA
Sep 25, 2026
Horizon Flexible Income ETF declares $0.189950 dividend · 
Seeking Alpha
FLXN Profile
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.
FLXN Performance
| Period | Price | Date | Change |
|---|